The very strange thing is that management did presentation days ago. Either they had something not disclosed or some one really challenged their ability to complete the trial successfully. A lot of delays and mess-ups could increase investors' mood. You draw your own conclusion here how they performed their jobs. I was tired as Long felt. Without XDA, there is no solution. XDA is their customer not patients, interesting!
I think possibly some of the recent private placement is selling, hedging their 10 cent stock. I expected it. I have been looking to buy stock near 10 cents. I nibbled just now and bought 50,000 shares about 12.3 cents. The conference call was all good with regards to the science and the trials, which I believe hold great promise.
The financial position is the only problem right now, and that will be solved. Just look at the board of directors. It's loaded with big money people, not doctors. That's a good thing. the founder of Quick and Reilly, founder of Ironwood hedge fund, Chris Forbes , Harlan Waksal and more, are all very capable of finding cash to keep the trials going, of that I have no doubt. There are a lot of big money players involved in this tiny unknown company. Why? the science is fantastic, and they must know it.
The only thing that sinks senesco is if the science does not work, and so far, it all looks good, as was reiterated in the conference call.
So, I'll take this as a buying opportunity, and increase my stake. If we see 10 cents I'll buy more, then it will be wait and see time until the summer, when we should have a much clearer picture of phase 1 trials and possibly evidence of efficacy at the higher dosages.